Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (4185)	7/10/1998 11:47:00 AM
From: B.REVERE	Read Replies (6) \| Respond to of 9523

Vasomax trials indicated 40% effectiveness at best. Dr. Lamm who probably knows the ED industry better than anyone else, thinks it's a good product but with a limited client base. Preffered viagra 6 months before the release date and continues to do so. Later, BR

To: Anthony Wong who wrote (4185)	7/10/1998 1:38:00 PM
From: Hesham	Read Replies (1) \| Respond to of 9523

Pfizer will have to buy back over a $1 billion of its own stock during the next 3 months! Q23) What is the status of Pfizer's share repurchase program? A23) In September 1996, Pfizer's board authorized the Company's repurchase of up to $2 billion of its common stock over 18-24 months. In the second quarter of 1998, Pfizer purchased 1.2 million shares at an average cost of about $102. Between September 1996 and the end of June 1998, Pfizer purchased 15.6 million shares at an average cost of about $60.